Idera Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.08.18	XERS Up 36% This Month, EVFM On Fast Track, NDRA Hitting Right Notes (RTTNews)
14.08.18	XBIO To Report Phase 2 Data This Year, VNRX Abuzz, ATRS To Face FDA In Sep (RTTNews)
10.08.18	ACER Already Up 61% This Month, CTXR Recoups Some Losses, Time To Check CKPT (RTTNews)
01.08.18	MYND Gives Back Gains, RSLS Hits New Low, IDRA Has Its Work Cut Out (RTTNews)
11.07.18	SCYX Takes Wings On DOVE Data, IDRA/BCRX Merger Terminated, ADXS Hits New Low (RTTNews)
20.06.18	Great Point Partners, LLC Remains Opposed To The BioCryst Pharmaceutical Proposed Merger With Idera Pharmaceuticals, Inc. (PR Newswire)
13.06.18	CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks (RTTNews)
12.06.18	Idera Pharma Says Phase 2 Trial Of IMO-8400 Fails To Meet Primary Endpoint (RTTNews)
02.04.18	RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals (PR Newswire)
19.02.18	Lifshitz & Miller LLP Announces Investigation of Advance Auto Parts, Inc., Ballard Power Systems, Inc., Connecture, Inc., Idera Pharmaceuticals, Inc., Impinj Inc., Obalon Therapeutics, Inc. (PR Newswire)
30.01.18	RM LAW Announces Investigation of Idera Pharmaceuticals, Inc. (PR Newswire)
22.01.18	SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of Idera Pharmaceuticals, Inc. - IDRA (PR Newswire)
22.01.18	BioCryst Pharma And Idera Pharma To Merge (RTTNews)
09.01.18	IKEA announces Better Chicken Program - for more sustainable agriculture (PR Newswire)
27.10.17	NEOS Soars On Buyout Bid, INSY Plunges On Founder's Arrest, CELG Bleeds (RTTNews)
18.09.17	Stock Performance Review on Biotech Industry -- Galena Biopharma, Idera Pharma, Ignyta, and Jaguar Health (PR Newswire)
05.07.17	Technical Insights on Biotech Stocks -- Idera Pharma, Pieris Pharma, Peregrine Pharma, and Ritter Pharma (PR Newswire)
24.05.17	How These Biotech Stocks are Faring? -- Idera Pharma, BioTime, RXi Pharma, and Tenax Therapeutics (PR Newswire)
12.04.17	FDA Approves 1st Drug For Tardive Dyskinesia, AGRX On Track, ITEK, AZRX On Watch (RTTNews)
28.03.17	Tendon Repair and Regenerative Biomedicine Market Fastest Growing Segment in Tissue Engineering Segment (PR Newswire)
28.03.17	Tendon Repair and Regenerative Biomedicine Market Fastest Growing Segment in Tissue Engineering Segment (PR Newswire)
23.03.17	Gainers & Losers Of Mar.22: MBRX, IDRA, GEMP, XENE, VBLT... (RTTNews)
01.03.17	Gainers & Losers Of Feb.28: KITE, PBMD, LIFE, VRX, PRGO... (RTTNews)
27.01.17	Research Reports Coverage on Biotech Stocks -- Idera Pharma, Ocular Therapeutix, Radius Health, and Grifols (PR Newswire)
16.12.16	Research Reports Coverage on Biotech Stocks -- Idera Pharma, bluebird bio, Corcept Therapeutics, and PhaseRx (PR Newswire)
27.09.16	ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial (RTTNews)
27.09.16	Idera Pharmaceuticals legt vielversprechende Daten zur laufenden klinischen Phase-I-Dosiseskalationsstudie von intratumoralem IMO-2125 in Verbindung mit Ipilimumab bei Patienten mit refraktärem met... (GlobeNewswire)
27.09.16	GNW-News: Idera Pharmaceuticals legt vielversprechende Daten zur laufenden klinischen Phase-I-Dosiseskalationsstudie von intratumoralem IMO-2125 in Verbindun... (dpa-afx)
26.09.16	Idera Pharmaceuticals Reports Promising Data from Ongoing Phase 1 Dose Escalation in Clinical Trial of Intra-tumoral IMO-2125 in Combination with Ipilimumab in Patients with PD-1 Refractory Metasta... (GlobeNewswire)
24.11.15	BMY's Opdivo Gets High-Five, XBIT Slammed For Messing Up Study, SMMT On Ascent (RTTNews)
19.05.15	ILMN Amps Up IP Suit, OFIX In A Fix, EBIO's Oasis Dries Up, ENDP Opens Wallet (RTTNews)
12.05.15	PTIE Working On Remoxy, CPRX Awaits Catalysts, There's Reason To Watch MCUR (RTTNews)
31.12.14	ARIA Widens Sales Turf, NRX Skips A Beat, NRDM Triples On Parkinson's Study (RTTNews)
30.12.14	Idera Pharma: FDA Grants Orphan Drug Designation For IMO-8400 - Quick Facts (RTTNews)
02.12.14	Idera Pharma Appoints Vincent Milano As CEO (RTTNews)
28.03.14	Idera Pharma Reports Positive Top-line Data From Phase 2 Trial Of IMO-8400 (RTTNews)
04.12.13	Idera Pharma Opens Enrollment For Phase 1/2 Trial Of IMO-8400 - Quick Facts (RTTNews)
25.09.13	Idera Pharma Prices Public Offering Of 13.73 Mln Shares At $1.55/shr (RTTNews)
10.07.13	Idera Pharma Appoints James Geraghty As Chairman (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Idera Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten